Informazioni
Non ci sono recensioni
Introduction: Integration of APP into Urologic Oncology Practice
Pages 1-3
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Chemotherapy and Immunotherapy in Urologic Oncology
A Guide for the Advanced Practice Provider
Trabulsi, Lallas, Calvaresi
Editore
Springer
Anno
2021
Pagine
307
ISBN
9783030520205
100,00 €
DA SCONTARE
This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP.
Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.
-
-
Overview and Active Surveillance of Prostate Cancer
Pages 7-19
-
Monitoring and Managing Men Following Initial Treatment of Prostate Cancer
Pages 21-28
-
Radical Prostatectomy and Survivorship After Radical Prostatectomy
Pages 29-41
-
Multimodal Treatment Plans in Prostate Cancer
Pages 43-53
-
Radiotherapy for Prostate Cancer
Pages 55-75
-
Androgen Deprivation Therapy
Pages 77-92
-
Second-Generation Androgen-Targeted Agents
Pages 93-103
-
Chemotherapy and Prostate Cancer
Pages 105-118
-
Radiopharmaceuticals for Prostate Cancer
Pages 119-132
-
Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer
Pages 133-138
-
Bladder Cancer: Overview, Epidemiology, Initial Presentation and Diagnosis
Pages 141-157
-
Intravesical Therapy for Non-muscle Invasive Urothelial Carcinoma
Pages 159-168
-
Bladder Cancer: Muscle-Invasive Disease, Neoadjuvant Chemotherapy, and Radical Cystectomy
Pages 169-185
-
Chemoradiation Bladder Preservation
Pages 187-192
-
Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy
Pages 193-200
-
Immunotherapy for Metastatic Urothelial Cancer
Pages 201-213
-
Novel and Experimental Strategies in the Treatment of Metastatic Urothelial Carcinoma
Pages 215-220
-
Upper Tract Urothelial Carcinoma
Pages 221-228
-
Kidney Cancer and Its Treatment
Pages 231-237
-
Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma
Pages 239-254
-
Immune Therapies for Metastatic Kidney Cancer
Pages 255-269
-
Novel Therapies for Renal Cell Carcinoma
Pages 271-275
-
Testicular Cancer
Pages 279-293
-
Penile Cancer
Pages 295-302
